You searched for side effects - Page 82 of 311 - Medivizor
Navigation Menu

Comparing the effectiveness of sacral neuromodulation and onabotulinumtoxinA for overactive bladder

Comparing the effectiveness of sacral neuromodulation and onabotulinumtoxinA for overactive bladder

Posted by on Sep 19, 2020 in Overactive bladder | 0 comments

In a nutshell This study reviewed the outcomes of onabotulinumtoxinA (BTX) and sacral neuromodulation (SNM) in the treatment of overactive bladder (OAB). Researchers suggested that both treatments improved the outcomes of these patients, but BTX may be associated with more complications. Some background OAB of an uncontrolled need to urinate...

Read More

Water vapor thermal therapy improves urinary symptoms associated with benign prostatic hyperplasia

Water vapor thermal therapy improves urinary symptoms associated with benign prostatic hyperplasia

Posted by on Sep 19, 2020 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study reviewed the effectiveness of water vapor thermal therapy (WVTT) as a treatment for urinary symptoms related to benign prostatic hyperplasia (BPH). Researchers suggested that this therapy improves the outcomes of these patients. Some background BPH consists of the enlargement of the prostate gland and is a common condition in...

Read More

FOLFOXIRI plus bevacizumab improves survival of patients with advanced colorectal cancer

FOLFOXIRI plus bevacizumab improves survival of patients with advanced colorectal cancer

Posted by on Sep 19, 2020 in Colorectal cancer | 0 comments

In a nutshell This study compared the survival outcomes of different chemotherapy treatments in patients with inoperable advanced colorectal cancer (CRC). Researchers suggested that FOLFOXIRI plus bevacizumab (Avastin) significantly improved the survival of these patients. Some background Around 20% of patients present with advanced CRC at diagnosis....

Read More

Dasatinib and decitabine treatment for patients with accelerated or blast phase chronic myeloid leukemia

Dasatinib and decitabine treatment for patients with accelerated or blast phase chronic myeloid leukemia

Posted by on Sep 17, 2020 in Leukemia | 0 comments

In a nutshell This study aimed to investigate if the combination of dasatinib and decitabine was safe and effective in patients with advanced chronic myeloid leukemia.   This study concluded that this treatment is safe and effective in these patients.   Some background Treatment of advanced-phase chronic myeloid...

Read More

Treating newly diagnosed Hodgkin lymphoma

Treating newly diagnosed Hodgkin lymphoma

Posted by on Sep 13, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This overview discusses initial treatment options for classical Hodgkin lymphoma (cHL).  Some background Classical HL is a cancer of the lymph nodes. Early-stage (stage I/II) cHL is contained to half the body, while advanced (stage III/IV) has spread to both the upper and lower halves of the body. Both early and advanced cHL have...

Read More

Bevacizumab plus mFOLFOX6 improves the outcomes of patients with colorectal cancer and liver metastasis

Bevacizumab plus mFOLFOX6 improves the outcomes of patients with colorectal cancer and liver metastasis

Posted by on Sep 9, 2020 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effects of bevacizumab (Avastin) combined with mFOLFOX6 (fluorouracil, leucovorin, and oxaliplatin) treatment in RAS-positive advanced colorectal cancer (CRC). Researchers suggested that this treatment improved the treatment and survival outcomes of patients with CRC and liver metastasis (spread to the...

Read More